From: Monoarticular juvenile idiopathic arthritis as a distinct clinical entity A proof-of-concept study
 |  | MonoJIA No.118†| OligoJIA No. 229 | p | |
---|---|---|---|---|---|
Sex (F) | 83 (70.3) | 191 (83.4) | 0.004 | ||
Age at onset (years) | 6.1 (3.9) | 4.7 (3.2) | 0.002 | ||
Presence of BJH | 73 (61.9) | 106 (46.3) | 0.006 | ||
Uveitis | 17 (14.4) | 78 (34.1) | 0.000 | ||
ANA+ | 81 (68.6) | 205 (89.5) | 0.000 | ||
Therapy | IACS | 107 (90.7) | 218 (95.2) | 0.102 | |
AIDs | 60 (50.8) | 199 (86.9) | 0.000 | ||
csDMARD | 22 (18.6) | 181 (79.9) | 0.000 | ||
bDMARD | 6 (5.1) | 83 (36.2) | 0.000 | ||
Long-term outcome | CR | 97 (82.2) | 101 (44.1) | 0.000 | |
CRM | 15 (12.7) | 97 (42.4) | |||
AD | 6 (5.1) | 31 (13.5) |